Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.030
+0.010 (0.98%)
At close: Aug 6, 2026, 4:00 PM EDT
0.9145
-0.1160 (-11.21%)
Pre-market: Aug 7, 2026, 7:45 AM EDT
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $19.84 million as of August 7, 2026. Its market cap has increased by 18.09% in one year.
Market Cap
19.84M
Enterprise Value
16.58M
1-Year Change
18.09%
Ranking
Category
Stock Price
$1.03
ChartMarket Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $19.84M, a decrease of -82.79%. That is a compound annual growth rate of -18.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 14.20M | 5.19% |
| Dec 31, 2025 | 13.50M | -34.47% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
| Mar 12, 2018 | 115.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 14.77M |
| KALA BIO | 13.81M |
| BioVie | 13.80M |
| Akari Therapeutics, | 13.64M |
| Tempest Therapeutics | 13.14M |
| BioLineRx | 13.05M |
| SeaStar Medical Holding | 12.83M |
| CalciMedica | 12.56M |